novel compound-7

N/A

Report date: 2025/06/11 10:38:55
NME

Base Information

Drug Namenovel compound-7
Drug Alias Nametankyrase inhibitor (Eluciderm)
ClassificationSmall molecules
Mechanisms of ActionTankyrase inhibitors
TargetsTankyrase
Therapy Area/IndicationsColorectal Neoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesEluciderm Inc
China Registration ClassN/A

Develop Information

Active CompaniesEluciderm Inc
Inactive CompaniesN/A
Active IndicationsColorectal Neoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A